Skip to main content
. 2020 Jul 28;11(30):2906–2918. doi: 10.18632/oncotarget.27658

Figure 1. CONSORT diagram.

Figure 1

Among the 83 patients who participated in the COMPASS trial, mRNA extraction was performed successfully for 78 patients (94%) and the expression levels of 127 genes were measurable in 46 patients (55%). Twenty-three patients received SC; the remaining 23 received PC.